LGVN News and Press, Longeveron Inc. From 01/05/22

MIAMI, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or the "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and certain life-threatening conditions, announced today the initiation of its Phase 2a cli...

MIAMI, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announced today that Geoff Green, Chief Executive Office...

Stocks carried their recent optimism into the long holiday weekend, scoring modest gains on Thursday. The rally included Macau casino stocks, which rose on a promising signal from Chinese regulators. The news sparked gains in Melco Resorts & Entertainment (NASDAQ:MLCO), Las Vegas Sands (N...

Shares of Longeveron (LGVN -16.1%) are down today after the company filed a prospectus in regards to a resale of ~2.4M shares. Although Longeveron will not receive proceeds from the resale of Class A shares, the company may receive up to $21.3M million if all warrants are exercised for cash a...

Gainers: Zhangmen Education (NYSE:ZME) +474%. 22nd Century Group (NASDAQ:XXII) +49%. Pasithea Therapeutics (NASDAQ:KTTA) +36%. Theseus Pharmaceuticals (NASDAQ:THRX) +32%. Qualigen Therapeutics (NASDAQ:QLGN) +32%. Allakos (NASDAQ:ALLK) +27%. REE Automotive (NASDAQ:REE) +26%. View (NASDAQ:VIEW)...

Palm Beach, FL –December 21, 2021 – FinancialNewsMedia.com News Commentary – Systemic mastocytosis is rare disease which affects very few people and it causes due to C-kit mutation which leads to higher number of mast cell production in the body resulting in...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shorted stocks continue to be of interest to retail traders looking for the next big day trade and we’re diving into some top candidates! Source: Shutterstock We’re pulling our short stock data from Twi...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Longeveron  (NASDAQ: LGVN ) is a clinical-stage biotechnology company, developing a clinical pipeline of cellular therapies for aging-related and life-threatening conditions. The company went public with its initi...

Context Therapeutics (NASDAQ:CNTX) +25% on positive ONA-XR data in early breast cancer study. American Virtual Cloud Technologies (NASDAQ:AVCT) +25% Kandy and Braidio announce expanded partnership to accelerate the delivery of digital transformation as a service solutions. Ener...

Up nearly 400% in the last month alone, Longeveron (NASDAQ: LGVN) is doubtlessly one of the more volatile biotechs in the longevity space. Between its brief dalliance with meme stock traders in November and recent progress with regulatory authorities, plenty of people have made a lo...